nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.275	0.359	CbGbCtD
Oxtriphylline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0964	0.126	CbGbCtD
Oxtriphylline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0907	0.118	CbGbCtD
Oxtriphylline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0907	0.118	CbGbCtD
Oxtriphylline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.082	0.107	CbGbCtD
Oxtriphylline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0687	0.0897	CbGbCtD
Oxtriphylline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0621	0.0812	CbGbCtD
Oxtriphylline—ADORA1—nerve—acquired immunodeficiency syndrome	0.00758	0.0544	CbGeAlD
Oxtriphylline—PDE3A—blood plasma—acquired immunodeficiency syndrome	0.00588	0.0422	CbGeAlD
Oxtriphylline—PDE3B—blood—acquired immunodeficiency syndrome	0.00353	0.0253	CbGeAlD
Oxtriphylline—PDE3B—bone marrow—acquired immunodeficiency syndrome	0.00341	0.0245	CbGeAlD
Oxtriphylline—HDAC2—retina—acquired immunodeficiency syndrome	0.0031	0.0223	CbGeAlD
Oxtriphylline—PDE3B—lung—acquired immunodeficiency syndrome	0.00309	0.0222	CbGeAlD
Oxtriphylline—ADORA2B—blood—acquired immunodeficiency syndrome	0.00292	0.021	CbGeAlD
Oxtriphylline—HDAC2—skin of body—acquired immunodeficiency syndrome	0.00272	0.0195	CbGeAlD
Oxtriphylline—PDE4C—nervous system—acquired immunodeficiency syndrome	0.00271	0.0195	CbGeAlD
Oxtriphylline—ADORA2B—vagina—acquired immunodeficiency syndrome	0.00271	0.0195	CbGeAlD
Oxtriphylline—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.00261	0.0188	CbGeAlD
Oxtriphylline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.0026	0.0187	CbGeAlD
Oxtriphylline—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00258	0.0186	CbGeAlD
Oxtriphylline—PDE4D—lung—acquired immunodeficiency syndrome	0.00258	0.0185	CbGeAlD
Oxtriphylline—ADORA2B—lung—acquired immunodeficiency syndrome	0.00256	0.0184	CbGeAlD
Oxtriphylline—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.00253	0.0182	CbGeAlD
Oxtriphylline—ADORA2A—blood—acquired immunodeficiency syndrome	0.00243	0.0175	CbGeAlD
Oxtriphylline—ADORA2B—nervous system—acquired immunodeficiency syndrome	0.00237	0.017	CbGeAlD
Oxtriphylline—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.00234	0.0168	CbGeAlD
Oxtriphylline—ADORA2B—central nervous system—acquired immunodeficiency syndrome	0.00228	0.0164	CbGeAlD
Oxtriphylline—PDE4A—lung—acquired immunodeficiency syndrome	0.00228	0.0164	CbGeAlD
Oxtriphylline—HDAC2—lymphoid tissue—acquired immunodeficiency syndrome	0.0022	0.0158	CbGeAlD
Oxtriphylline—PDE3B—brain—acquired immunodeficiency syndrome	0.00219	0.0157	CbGeAlD
Oxtriphylline—HDAC2—digestive system—acquired immunodeficiency syndrome	0.00218	0.0156	CbGeAlD
Oxtriphylline—PDE3A—blood—acquired immunodeficiency syndrome	0.00215	0.0155	CbGeAlD
Oxtriphylline—PDE3B—lymph node—acquired immunodeficiency syndrome	0.00211	0.0152	CbGeAlD
Oxtriphylline—PDE4C—brain—acquired immunodeficiency syndrome	0.00207	0.0149	CbGeAlD
Oxtriphylline—HDAC2—blood—acquired immunodeficiency syndrome	0.00207	0.0149	CbGeAlD
Oxtriphylline—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.00202	0.0145	CbGeAlD
Oxtriphylline—HDAC2—bone marrow—acquired immunodeficiency syndrome	0.00201	0.0144	CbGeAlD
Oxtriphylline—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.00197	0.0142	CbGeAlD
Oxtriphylline—ADORA1—vagina—acquired immunodeficiency syndrome	0.00195	0.014	CbGeAlD
Oxtriphylline—HDAC2—vagina—acquired immunodeficiency syndrome	0.00192	0.0138	CbGeAlD
Oxtriphylline—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.0019	0.0136	CbGeAlD
Oxtriphylline—PDE3A—lung—acquired immunodeficiency syndrome	0.00189	0.0136	CbGeAlD
Oxtriphylline—ADORA1—lung—acquired immunodeficiency syndrome	0.00184	0.0132	CbGeAlD
Oxtriphylline—PDE4D—brain—acquired immunodeficiency syndrome	0.00183	0.0131	CbGeAlD
Oxtriphylline—HDAC2—lung—acquired immunodeficiency syndrome	0.00182	0.0131	CbGeAlD
Oxtriphylline—ADORA2B—brain—acquired immunodeficiency syndrome	0.00181	0.013	CbGeAlD
Oxtriphylline—PDE4D—lymph node—acquired immunodeficiency syndrome	0.00177	0.0127	CbGeAlD
Oxtriphylline—ADORA1—nervous system—acquired immunodeficiency syndrome	0.0017	0.0122	CbGeAlD
Oxtriphylline—HDAC2—nervous system—acquired immunodeficiency syndrome	0.00168	0.0121	CbGeAlD
Oxtriphylline—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00165	0.0119	CbGeAlD
Oxtriphylline—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.00164	0.0118	CbGeAlD
Oxtriphylline—HDAC2—central nervous system—acquired immunodeficiency syndrome	0.00162	0.0116	CbGeAlD
Oxtriphylline—PDE4A—brain—acquired immunodeficiency syndrome	0.00162	0.0116	CbGeAlD
Oxtriphylline—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00156	0.0112	CbGeAlD
Oxtriphylline—PDE4B—blood—acquired immunodeficiency syndrome	0.00155	0.0112	CbGeAlD
Oxtriphylline—ADORA2A—brain—acquired immunodeficiency syndrome	0.00151	0.0108	CbGeAlD
Oxtriphylline—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.0015	0.0108	CbGeAlD
Oxtriphylline—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.0015	0.0107	CbGeAlD
Oxtriphylline—SLC22A7—brain—acquired immunodeficiency syndrome	0.0015	0.0107	CbGeAlD
Oxtriphylline—PDE4B—vagina—acquired immunodeficiency syndrome	0.00144	0.0103	CbGeAlD
Oxtriphylline—PDE4B—lung—acquired immunodeficiency syndrome	0.00136	0.00978	CbGeAlD
Oxtriphylline—PDE3A—brain—acquired immunodeficiency syndrome	0.00134	0.0096	CbGeAlD
Oxtriphylline—ADORA1—brain—acquired immunodeficiency syndrome	0.0013	0.00935	CbGeAlD
Oxtriphylline—PDE3A—lymph node—acquired immunodeficiency syndrome	0.00129	0.00928	CbGeAlD
Oxtriphylline—HDAC2—brain—acquired immunodeficiency syndrome	0.00129	0.00924	CbGeAlD
Oxtriphylline—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00126	0.00905	CbGeAlD
Oxtriphylline—ADORA1—lymph node—acquired immunodeficiency syndrome	0.00126	0.00904	CbGeAlD
Oxtriphylline—HDAC2—lymph node—acquired immunodeficiency syndrome	0.00124	0.00893	CbGeAlD
Oxtriphylline—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00121	0.00872	CbGeAlD
Oxtriphylline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.001	0.00719	CbGeAlD
Oxtriphylline—PDE4B—brain—acquired immunodeficiency syndrome	0.000964	0.00692	CbGeAlD
Oxtriphylline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000954	0.00685	CbGeAlD
Oxtriphylline—PDE4B—lymph node—acquired immunodeficiency syndrome	0.000931	0.00669	CbGeAlD
Oxtriphylline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000836	0.006	CbGeAlD
Oxtriphylline—PDE3A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000164	0.00173	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000164	0.00173	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000163	0.00172	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000163	0.00172	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000163	0.00171	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000161	0.00169	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000161	0.00169	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000161	0.00169	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000161	0.00169	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00016	0.00169	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00016	0.00169	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00016	0.00168	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000159	0.00168	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000158	0.00166	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000158	0.00166	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000158	0.00166	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000158	0.00166	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000156	0.00164	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000156	0.00164	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000155	0.00163	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000155	0.00163	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000155	0.00163	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000153	0.00161	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000153	0.00161	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000153	0.00161	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000153	0.0016	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000152	0.0016	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00015	0.00158	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00015	0.00158	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00015	0.00157	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00015	0.00157	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000149	0.00156	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000148	0.00155	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000146	0.00154	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000146	0.00154	CbGpPWpGaD
Oxtriphylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000145	0.00153	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000145	0.00153	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000143	0.0015	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000142	0.00149	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000141	0.00149	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000141	0.00148	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000141	0.00148	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00146	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00146	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000139	0.00146	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000138	0.00145	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000137	0.00144	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000137	0.00144	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000137	0.00144	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000136	0.00143	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000134	0.00141	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000132	0.00139	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000132	0.00139	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000131	0.00138	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000131	0.00138	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00013	0.00137	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000128	0.00134	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000127	0.00134	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000126	0.00132	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000126	0.00132	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000126	0.00132	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000125	0.00131	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000124	0.00131	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000124	0.00131	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000124	0.0013	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000124	0.0013	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000122	0.00129	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000122	0.00128	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000122	0.00128	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000122	0.00128	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000121	0.00127	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000121	0.00127	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00012	0.00126	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00012	0.00126	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00012	0.00126	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00012	0.00126	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000119	0.00126	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000119	0.00125	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000119	0.00125	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000118	0.00124	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000118	0.00124	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000116	0.00122	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000116	0.00122	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000116	0.00121	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000115	0.00121	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000115	0.00121	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000114	0.0012	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000114	0.0012	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000114	0.0012	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000113	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000113	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000113	0.00118	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000111	0.00117	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000111	0.00117	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000111	0.00116	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00011	0.00116	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00011	0.00116	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00011	0.00116	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00011	0.00115	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00011	0.00115	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000109	0.00114	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000109	0.00114	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000108	0.00114	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00113	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00113	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000107	0.00113	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000106	0.00112	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000106	0.00111	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000105	0.00111	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000105	0.0011	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000104	0.0011	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000104	0.0011	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000104	0.00109	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000103	0.00108	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000103	0.00108	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000103	0.00108	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000102	0.00107	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000101	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000101	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.0001	0.00105	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—ALB—acquired immunodeficiency syndrome	9.94e-05	0.00105	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.92e-05	0.00104	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.92e-05	0.00104	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CXCR4—acquired immunodeficiency syndrome	9.86e-05	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.77e-05	0.00103	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.77e-05	0.00103	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.77e-05	0.00103	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.66e-05	0.00102	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.64e-05	0.00101	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.53e-05	0.001	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.48e-05	0.000997	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.48e-05	0.000997	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.44e-05	0.000992	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.32e-05	0.00098	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.32e-05	0.00098	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.22e-05	0.000969	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.18e-05	0.000965	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.1e-05	0.000957	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	9.04e-05	0.00095	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.96e-05	0.000942	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.88e-05	0.000933	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.88e-05	0.000933	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.84e-05	0.000929	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.73e-05	0.000918	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.71e-05	0.000915	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.63e-05	0.000908	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.63e-05	0.000908	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.31e-05	0.000874	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.31e-05	0.000874	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.26e-05	0.000869	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.21e-05	0.000863	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.21e-05	0.000863	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.2e-05	0.000862	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.15e-05	0.000857	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.14e-05	0.000856	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.12e-05	0.000853	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—IL2—acquired immunodeficiency syndrome	8.06e-05	0.000848	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.03e-05	0.000844	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.91e-05	0.000831	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.55e-05	0.000793	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	7.48e-05	0.000786	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.44e-05	0.000783	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.44e-05	0.000782	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.34e-05	0.000772	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.34e-05	0.000772	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.32e-05	0.00077	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.22e-05	0.000759	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.21e-05	0.000758	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.18e-05	0.000755	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.1e-05	0.000747	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.09e-05	0.000746	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7e-05	0.000736	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.99e-05	0.000735	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	6.95e-05	0.000731	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.9e-05	0.000726	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.9e-05	0.000726	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.88e-05	0.000724	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.82e-05	0.000717	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CCR5—acquired immunodeficiency syndrome	6.76e-05	0.00071	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.75e-05	0.00071	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.7e-05	0.000704	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.65e-05	0.000699	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.57e-05	0.00069	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.55e-05	0.000689	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.55e-05	0.000689	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.5e-05	0.000683	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.47e-05	0.00068	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.42e-05	0.000675	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.42e-05	0.000675	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.39e-05	0.000672	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.37e-05	0.00067	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.35e-05	0.000668	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.32e-05	0.000665	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.25e-05	0.000657	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.25e-05	0.000657	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.23e-05	0.000655	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.15e-05	0.000647	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.14e-05	0.000645	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.08e-05	0.000639	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.06e-05	0.000637	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	5.96e-05	0.000627	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.95e-05	0.000625	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.92e-05	0.000622	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.79e-05	0.000608	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.7e-05	0.000599	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.63e-05	0.000592	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.57e-05	0.000586	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.51e-05	0.000579	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.25e-05	0.000552	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.17e-05	0.000544	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.07e-05	0.000533	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.88e-05	0.000513	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.81e-05	0.000505	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.74e-05	0.000498	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.73e-05	0.000497	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.4e-05	0.000462	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.3e-05	0.000452	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CD4—acquired immunodeficiency syndrome	4.24e-05	0.000446	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.24e-05	0.000446	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.22e-05	0.000444	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.87e-05	0.000407	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.85e-05	0.000405	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.75e-05	0.000395	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.74e-05	0.000393	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.69e-05	0.000388	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.67e-05	0.000386	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.51e-05	0.000369	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.5e-05	0.000368	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.42e-05	0.000359	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.4e-05	0.000358	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.29e-05	0.000346	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.27e-05	0.000344	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.25e-05	0.000342	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.24e-05	0.00034	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.73e-05	0.000287	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.54e-05	0.000267	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000266	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000262	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.34e-05	0.000246	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—acquired immunodeficiency syndrome	2.29e-05	0.000241	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.28e-05	0.000239	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.21e-05	0.000232	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.17e-05	0.000228	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.07e-05	0.000217	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.01e-05	0.000211	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.93e-05	0.000203	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.91e-05	0.000201	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000169	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.49e-05	0.000157	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.04e-05	0.000109	CbGpPWpGaD
